When:
July 14, 2020 @ 12:00 pm – 1:30 pm
2020-07-14T12:00:00-04:00
2020-07-14T13:30:00-04:00

Hepatitis C Virus (HCV) screening is recommended because of the known benefits of care and treatment in reducing the risk, the potential public health benefit of reducing transmission through early treatment, viral clearance, and reduced risk behaviors. Improved identification of active HCV infection and treatment advances will have limited impact on HCV-related morbidity and mortality without improvement in linkage to care.

Registration:

You may this meeting from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/227275549

You can also dial in using your phone. United States: +1 (224) 501-3412 / Access Code: 227-275-549

More information